24/7 Patient Assistance: 760-405-8205

Michael Burdick, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Burdick graduated the medical school from the Virginia Commonwealth University School of Medicine. He did his internship at the University of Washington and completed his residency program at the Cleveland Clinic Foundation. He is specialized in Radiation Oncology and board certified in Radiation Oncology. Dr. Burdick has been in practice for more than 11 years and is affiliated with the Good Samaritan Hospital and the San Leandro Hospital. During his career, he also contributed to 9 publications of medical interest.


  • Education & Training

    dept_icon

    Virginia Commonwealth University School of Medicine

    Medical School

    dept_icon

    University of Washington

    Internship

    dept_icon

    Cleveland Clinic Foundation

    Residency

  • Board Certifications

    American Board of Radiology - Radiation Oncology

  • Hospital & Practice

    Good Samaritan Hospital

    Languages: English/Spanish

    (213) 977-2121

    1225 Wilshire Blvd

    Los Angeles, California 90017

    Read More

    San Leandro Hospital

    Languages: English/Spanish

    (510) 357-6500

    13855 E 14th St

    San Leandro, California 94578

    Read More

    UCLA Medical Center, Santa Monica

    Languages: English/Spanish

    (424) 259-6000

    1250 16th St

    Santa Monica, California 90404

    Read More
  • Publications & Memberships

    Dr. Michael Burdick has contributed to 3 publications.

    Marginal Recurrence Requiring Salvage Radiotherapy after Stereotactic Body Radiotherapy for Spinal Metastases.

    Koyfman, S.A., Djemil, T., Burdick, M.J., Woody, N., Balagamwala, E.H., Reddy, C.A., Angelov, L., Suh, J.H., Chao, S.T.; Int J Radiat Oncol Biol Phys. 2012 May 1.

    See more >>

    External beam radiotherapy followed by 90Y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma.

    Burdick, M.J., Neumann, D., Pohlman, B., Reddy, C.A., Tendulkar, R.D., Macklis, R.; Int J Radiat Oncol Biol Phys. 2011 Mar 15.

    See more >>

    Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body ...

    Burdick, M.J., Stephans, K.L., Reddy, C.A., Djemil, T., Srinivas, S.M., Videtic, G.M.; Int J Radiat Oncol Biol Phys. 2010 Nov 15.

    See more >>